Two-thirds of American men will have noticeable hair loss by age 35, with some 85% having significantly thinning hair by age 50, according to the American Hair Loss Association. Up to 40% of ...

Company Releases Comprehensive Ingredient Research Guide to Address Consumer Confusion in Growing Brain Health Supplement Market ...

Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader ...

September 21, 2025, marked the 32nd World Alzheimer’s Day. Alzheimer’s disease (AD) is the primary cause of dementia. Often ...

Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis Ascletis ...

Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median progression-free ...

Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median ...

The hidradenitis suppurativa market is poised for strong growth, driven by increasing disease awareness, earlier diagnosis, and expanding treatment access. Advances in biologic and targeted therapies, ...

Eli Lilly and Company’s LLY stock has risen 9.5% in a month, mainly due to the recent recovery in the pharma sector. The drug and biotech sector has recovered in the past month, with large drugmakers ...

Early broadly neutralising antibody responses against the E1E2 glycoprotein seem to be important for preventing persistence ...